In pharmaceutical research and development as well as basic scientific research, recombinant proteins serve not only as essential research tools but also as potential therapeutic agents or key factors. However, as an inherent component of the Gram-negative bacterial cell wall, endotoxin (lipopolysaccharide/LPS) frequently acts as an "invisible contaminant" in protein products, leading to severe experimental interference. Even trace amounts of residual endotoxin are sufficient to activate immune cells and trigger non-specific inflammatory responses, ultimately resulting in "false-positive" or irreproducible experimental data. To prevent adverse effect induced by endotoxins, food and drug administrations and health regulatory agencies worldwide have established strict threshold standards to ensure the safety of injectable drugs, medical devices, and other products that come into contact with the human body.
This talk will delve into the potential risks associated with endotoxin contamination in immunological and cellular assays, and further introduce Sino Biological’s ultra-low endotoxin protein solutions designed to meet the most stringent experimental demands.
Learning Objectives:
1. Describe the sources and properties of endotoxins.
2. Analyze the risks of endotoxin contamination in experiments.
3. Discuss industry standards and ultra-low endotoxin solutions.